Episode 305: 304. METHODS MONDAY- What is Power?

Episode 305: 304. METHODS MONDAY- What is Power?

What is the power of a study—what is the power calculation?

Often say it is the number of people in a study. Power is the probably to correctly reject the null hypothesis. Said differently power is the probability we will correctly get a small pvalue

But a power calculation is slightly more than that it is the number of people required to adequetyly statistically calculate the number of people that would be necessary to reject your null hypothesis of no difference when there actually is a difference.

Lets say we have a blood pressure drug and we want to see if it works

Well if you only enroll a small number of people you might not be able to tell a difference between those in the active and those in the control arm

Remember depending on baseline bp you might only see a 4-5mmg hg improvement in your blood pressure and in almost every trial I have ever seen even those individuals that get the placebo have a 1-2mm hg improvement in their bp so with large confidence intervals that are likely to overlap with just a small number of people being tested you wont find a statistical difference between the two drugs. You will end up accepting the null hypothesis since you will see overlap, this is sad because maybe there is real difference but you didn’t enroll enough people to find that difference.

But lets say you want to enroll 5 million people in your trial

This is great, you will have much smaller confidence intervals and you will be able to see there is a difference and properly reject the null hypothesis and be able to get an answer but you might waist years or decades trying to enroll that many people. This is timely and expensive.

Avsnitt(387)

Episode 369: 380. REPOST mammo part 2

Episode 369: 380. REPOST mammo part 2

Mammograms

24 Feb 202520min

Episode 368: 379. REPOST mammogram part 1

Episode 368: 379. REPOST mammogram part 1

379. REPORT mammogram part 1

18 Feb 202519min

Episode 367: 378. What is the Best Way To Treat Ductal Carcinoma In Situ

Episode 367: 378. What is the Best Way To Treat Ductal Carcinoma In Situ

https://jamanetwork.com/journals/jama/article-abstract/2828218DCIS is a non-invasive form of breast cancer, meaning the abnormal cells are contained within the milk ducts. For years, the standard trea...

12 Feb 20258min

Episode 366: 377. Does How Long You Have Hypertension Matter?

Episode 366: 377. Does How Long You Have Hypertension Matter?

Association of Duration of Recognized Hypertension and Stroke Risk: The REGARDS Study   (Transition Music - Short and subtle - 2 seconds)Host:  Hypertension is a well-known risk factor for stroke, but...

11 Feb 20257min

Episode 365: 366. Association of dose of inhaled corticosteroids and frequency of adverse events

Episode 365: 366. Association of dose of inhaled corticosteroids and frequency of adverse events

Bloom CI et al. Association of dose of inhaled corticosteroids and frequency of adverse events. Am J Respir Crit Care Med 2025 Jan; 211:54. (https://doi.org/10.1164/rccm.202402-0368OC)  Bloom and coll...

7 Feb 20256min

Episode 364: 364. The safety and efficacy of sodium–glucose cotransporter 2 inhibitor in hospitalized patients

Episode 364: 364. The safety and efficacy of sodium–glucose cotransporter 2 inhibitor in hospitalized patients

Gao FM et al. A systematic review and meta-analysis on the safety and efficacy of sodium–glucose cotransporter 2 inhibitor use in hospitalized patients. Diabetes Care 2024 Dec 1; 47:2275. (https://doi...

4 Feb 20257min

Episode 363: 262. Myocardial injury in patients with hip fracture

Episode 363: 262. Myocardial injury in patients with hip fracture

Is accelerated surgery for hip fracture better for high-risk patients? A recent substudy of the HIP ATTACK trial has shed new light on this topic. The original trial, published in 2020, compared accel...

31 Jan 20255min

Episode 362: 261. What to do with the beta blocker following a Myocardial Infarction

Episode 362: 261. What to do with the beta blocker following a Myocardial Infarction

Today, we're discussing two groundbreaking studies from 2024 that challenge our understanding of β-blocker therapy for secondary prevention after myocardial infarction, or MI.Let's start with a Swedis...

15 Jan 20256min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
alska-oss
not-fanny-anymore
johannes-hansen-podcast
rss-vuxna-pa-latsas
angestpodden
rss-viktmedicinpodden
sa-in-i-sjalen
sova-med-dan-horning
sexnoveller-deluxe
rss-psykoterapipodden
brottarbroder
rss-aldrig-lagom
rss-basta-livet
rss-sjalsligt-avkladd
giggles-med-wiggles
rss-the-house-podcast-3